Amphastar Pharmaceuticals Assets & Liabilities Overview 2012-2023 | AMPH
Amphastar Pharmaceuticals assets & liabilities overview from 2012 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
Amphastar Pharmaceuticals Annual Assets & Liabilities Overview (Millions of US $) |
Amphastar Pharmaceuticals Quarterly Assets & Liabilities Overview (Millions of US $) |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$2.093B |
$0.644B |
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|